Dysregulation of apoptotic pathways allows cancer cells to evade cell death, for example, through overexpression of anti-apoptotic proteins like Bcl-2 or downregulation of pro-apoptotic factors, thereby diminishing PTX-induced cytotoxicity. Here, BCL2 is linked to cancer.